Gene and cell-based therapies are considered to be potentially powerful new approaches for the management of cystic fibrosis (CF) lung disease. Despite tremendous efforts that have been made, especially in studies to understand the obstacles to gene delivery, major challenges to the application of these approaches remain to be solved. This article will review the advancements made and challenges remaining in the development of viral vector-mediated and cell-based approaches to treat patients with CF.
ABSTRACT
PUBLICATION RECORD
- Publication year
2007
- Venue
Molecular Therapy
- Publication date
2007-02-01
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
CONCEPTS
- cell-based therapy
A treatment approach that uses cells as the therapeutic agent, including transplanted or engineered cells.
Aliases: cell-based approach
- cystic fibrosis lung disease
The pulmonary disease manifestation of cystic fibrosis that is the target of the therapies discussed.
Aliases: CF lung disease
- gene delivery obstacles
Technical barriers that reduce the efficiency or practicality of delivering genetic material to airway cells.
Aliases: obstacles to gene delivery, gene-delivery barriers
- viral vector-mediated therapy
A gene-delivery strategy that uses viral vectors to introduce therapeutic material into target cells.
Aliases: viral vector-mediated approach, viral vector therapy
REFERENCES
CITED BY
Showing 1-69 of 69 citing papers · Page 1 of 1